<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02811198</url>
  </required_header>
  <id_info>
    <org_study_id>SBIO-01</org_study_id>
    <nct_id>NCT02811198</nct_id>
  </id_info>
  <brief_title>Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality</brief_title>
  <official_title>Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <brief_summary>
    <textblock>
      The ultimate aim of this study is to identify a biomarker of suicide risk in MDD by measuring
      the &quot;hedonic spectrum&quot; (pain and reward responsivity), attention and its associated brain
      structures using brain scans (fMRI and DTI), as well as the stability of markers over time.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Potential biomarkers for suicide risk including brain scans, genomic or proteomic makers, task performance</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>Suicide</condition>
  <condition>Suicidal Ideation</condition>
  <arm_group>
    <arm_group_label>MDD with SI and No Attempt</arm_group_label>
    <description>Subjects will have MDD with current MDE, current suicidal ideation and no lifetime suicide attempts</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MDD with SI and Recent Attempt</arm_group_label>
    <description>Subjects with have MDD with current MDE, current suicidal ideation and a suicide attempt within the past 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MDD with no SI and Lifetime Attempt</arm_group_label>
    <description>Subjects with MDD and current MDE but no current suicidal ideation and a lifetime suicide attempt.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Subjects will have no personal or family psychiatric history and no suicide attempts.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>MDD with SI and No Attempt</arm_group_label>
    <arm_group_label>MDD with SI and Recent Attempt</arm_group_label>
    <arm_group_label>MDD with no SI and Lifetime Attempt</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be collected for genetic and proteomic analysis. Saliva samples will be
      collected to measure cortisol levels.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will recruited from Mental Health Clinics at St. Michael's Hospital from Mood
        Disorders Clinics and self-referrals from advertisements in Mental Health Department.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. DSM-5 criteria for Major Depressive Episode within a MDD, confirmed through MINI
             diagnosis104

          2. Ages between 18 and 70 years

          3. Hamilton Depression Rating Scale - 17 item (HAMD-17) &gt; 14

          4. Capable of giving informed consent

          5. Groups 1 and 2 participants only: HAMD-17 item 3 (suicide) &gt; 2

          6. Group 2 participants only: positive history of a suicide attempt within the last six
             months

          7. Group 3 participants only: positive history of a lifetime suicide attempt

        Exclusion Criteria:

          1. Pregnancy/lactation

          2. Medical condition requiring immediate investigation or treatment

          3. Recent (&lt; 6 months)/current history of drug abuse/dependence (other than caffeine, or
             nicotine)

          4. Lifetime history of psychosis, Bipolar I or Bipolar II; other Axis I comorbidities are
             allowable

          5. No current Axis II diagnosis, confirmed by International Personality Disorder
             Examination (IPDE)

          6. Participation in experimental treatment trials for the study duration.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sakina Rizvi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Edgar, HBSc</last_name>
    <phone>416-864-6099</phone>
    <email>edgarn@smh.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1M8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Edgar, HBSc</last_name>
      <phone>416-864-6099</phone>
      <email>edgarn@smh.ca</email>
    </contact>
    <investigator>
      <last_name>Sakina Rizvi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2016</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Sakina Rizvi</investigator_full_name>
    <investigator_title>Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicidal Ideation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

